News

Cartesian Therapeutics has created its therapy, Descartes-30, the first RNA cell therapy for acute respiratory distress syndrome (ARDS), and the company is now recruiting for a clinical trial.

Individuals with the allele APOE E4/E4 were found to be more susceptible.

A Q&A surrounding the two technologies with investigators from the Wistar Institute.

The federal agency has asked Johnson & Johnson to discard its COVID-19 vaccine made at a plant in Baltimore.

Cooler weather and higher population density were linked with higher transmission.

Compared to placebo, patients treated with bamlanivimab had reduced incidence of mild or worse COVID-19 infection.

The committee members discussed their concerns about having sufficient data to make an informed decision around the risk vs. benefits for looking at potential FDA approvals for vaccines in this population group.

Entry bans, travel bans and lock downs all helped to curb the spread of the virus.

The company’s submission is for teens 12-17 years old and is based on data from its phase 2/3 trial studying its mRNA-1273 vaccine.

The therapy was associated with reduced mortality, cellular senescence and inflammatory markers.

Paratek’s omadacycline (Nuzyra) is granted approval for an oral-only dosing regimen in adults.

Rapid respiratory virus test results for children in an emergency department could be received too late to inform antibiotic prescribing.

The agreement brings the total number of doses bought by the United States to 800 million.

The mutation, first identified in India, has been growing here and is disproportionately affecting younger people in the UK. The CDC and the Biden Administration continue to express the importance of vaccination as a way to combat the strain.

The public health agency eased travel recommendations for over 110 countries.

Diets consisting mainly of pants and fish were associated with lower chances of moderate to severe infections.

The vaccine covers 13 S. pneumoniae serotypes plus an additional 7.

Rates of HIV diagnoses among adults and adolescents is higher in southern states, and organizations are looking to reverse this trend and address inequities.

Pediatric patients with COVID-19 showed higher rates of symptoms than those with influenza.

The therapy was associated with 95,000 fewer deaths through early March of 2021.

In a population-based cohort study with a mean follow-up of 3.6 years, childhood outcomes showed no statistically significant associations with any adverse health conditions.

High admission plasma ACE2 was associated with an increased maximal illness severity within 28 days.

The company recently began its phase 2/3 trial for its investigational therapy.

The therapy builds on the Prevnar 13 platform with an additional 7 serotypes.

Hesitancy is a hurdle we have been struggling with in general when it comes to vaccines, but even more so when it comes to COVID-19. Throw politicization and the nuances of EUA into this mix, and it’s not surprising we’re having to work exceedingly hard to expand vaccine uptake.

Deaths continue to plunge in Brazil as more vaccinations are administered.

With the US Centers for Disease Control and Prevention's recent change to mask guidance for vaccinated people, some confusion ensued and left state governments and businesses scrambling to react to the update.